healer products certificates of analysis (coa)

Healer Products Certificates of Analysis (COA)

Dear Healer Patron,

We are committed to producing high quality, clean, and accurately labeled cannabis products

to help you feel your best. As you’ll see in the following pages, we invest in the most thorough

testing available in our region, not just for the content of medicinal components, but also for

the absence of pesticides, toxic solvents, heavy metals, and microbiological contaminants.

To be transparent and earn your trust, our third-party laboratory certificates of analysis are

attached.

Having previously owned and participated in a cannabis analytic laboratory for several years, I

understand the inherent challenges related to reproducibility, calibration, and validation with

peer laboratories. In the cannabis analytic industry, potency results are considered accurate

within 10% deviation from the actual value. That’s why after Healer performs its own internal

analytics, we send samples of our bulk extracts and final products to at least one third-party

lab, and sometimes two.

If you have any questions about the data on the following pages, we’d love to hear from you.

Thank you for choosing Healer and taking a powerful step for your good health.

Sincerely,

Dr. Dustin Sulak

CANNABINOIDS Cannabinoid Concentration

mg/ml

TOTAL 53.331

CBC 3.25

CBCA <LOQ*

CBD 3.45

CBDA 2.55

CBDV 0.73

CBDVA

CBG 36.8

CBGA 6.02

CBL

CBLA

CBN

CBNA 8-THC 9-THC 0.55 10-THC

EXO-THC

THCA

THCV

THCVA 3rd Party Tested By: Nova Analytic

Labs

3rd Party Testing ID: CBG.T.21.001-CANN

NAL-211105-143

*<LOQ= Compound present in detectable amounts

below limit of quantitation for data reporting

TERPENES Terpene Concentration

mg/ml

TOTAL 2.519

PERCENT BY Wt 0.269%

-Caryophyllene 1.508

-Humulene 0.378

D-Limonene

-Pinene

-Myrcene 0.184

-Pinene

Linalool

Camphene

-Bisabolol 0.264

-Terpinene

Terpinolene

P-Cymene

Isopulegol

Geraniol

Cis-Nerolidol

Eucalyptol 3-Carene

Caryophyllene

Oxide 0.184

-Ocimene

-Terpinene

-Ocimene

Trans-Nerolidol 3rd Party Tested By: Nova Analytic Labs

3rd Party Testing ID: CBG.T.21.001-TERP

NAL-211105-144 **Results converted from mg/g to mg/ml using

density 0.9364 from Cannabinoid Analysis

CBG.T.21.001-CANN (NAL-211105-143).

HEAVY METALS

TEST RESULTS

Arsenic Pass-None Detected

Cadmium Pass-None Detected

Lead Pass-None Detected

Mercury Pass-None Detected 3rd Party Tested By: Nova Analytic Labs 3rd Party Testing ID: CBG.T.21.001-CONT

NAL-211105-145

MICROBIOLOGICAL CONTAMINANTS

TEST RESULTS

Enterobacter Pass-None Detected

Coliform Pass-None Detected

Aerobic Bacteria Pass-None Detected

Yeast and Mold Pass-None Detected

Salmonella Pass-None Detected

E.Coli Pass-None Detected

3rd Party Tested By: Nova Analytic Labs 3rd Party Testing ID: CBG.T.21.001-CONT

NAL-211105-145

PESTICIDES

TEST RESULT

Bifenthrin Pass-None Detected

Cyfluthrin Pass-None Detected

Daminozide Pass-None Detected

Etoxazole Pass-None Detected

Imazalil Pass-None Detected

Myclobutanil Pass-None Detected

Spiromesifen Pass-None Detected

Trifloxystrobin Pass-None Detected 3rd Party Tested By: Nova Analytic Labs 3rd Party Testing ID: H.21-001 PESTICIDE TEST

NAL-210702-015

*Concentrated Formula Tested

RESIDUAL SOLVENTS

TEST RESULTS

Ethanol Pass-285 g/g Detected

(0.285mg/g) 3rd Party Tested By: Nova Analytic Labs 3rd Party Testing ID: CBG.T.21.001-CONT

NAL-211105-145

*For full list of solvents see attached

Whole Plant

Hemp CBG Drops Batch ID: CBG.T.21.001

Product Type:

6:1 CBG:CBGA Tincture

Product Expiration Date:

11/05/2023

COA Issue Date:

11/05/2021

Ingredients: Organic MCT

Coconut Oil, MOFGA Certified

Clean Maine Industrial Hemp

<0.3% THC, Traces of Ethyl

Alcohol (Ethanol).

Strains: Stem Cell CBG, White

CBG

3rd Party

Lab Results

Attached

CERTIFICATE OF ANALYSIS* F O R Q U A L I T Y A S S U R A N C E P U R P O S E S . N O T A M A I N E C O M P L I A N C E C E R T I F I C A T E .

C B G .T. 2 1 . 0 0 1 - C A N N ( T I N C T U R E ) // P RO D U C E D : N OV 1 0 , 2 0 2 1

C L I E N T : H E A L E R H E M P L L C // B AT C H : PA S S E D A S M A I N E I N D U S T R I A L H E M P

C A N . 1 : P O T E N C Y & C A N N A B I N O I D P R O F I L E B Y H P L C- U VP R E PA R AT I O N : N O V 0 9 , 2 0 2 1 // A N A LY S I S : N O V 1 0 , 2 0 2 1

* * T O T A L C B D = ( C B D A X 0 . 8 7 7 ) + C B D* * T O T A L T H C = ( T H C A X 0 . 8 7 7 ) + T H CR e p o r t e d o n a n a s r e c e i v e d b a s i s1 0 0 0 µ g / g = 1 m g / g

https://lims.tagleaf.com/coa_/phdjnr2ceQ

* F O R Q U A L I T Y A S S U R A N C E P U R P O S E S . N O T A M A I N E C O M P L I A N C E C E R T I F I C A T E .

A L L T E S T S W E R E P E R F O R M E D I N A C C O R D A N C E W I T H T H E R U L E S A N D R E G U L A T I O N S S E T F O R T H I N T H E M A I N E A D U L T U S E P R O G R A M . L A B O R A T O R Y S A M P L I N G P R O T O C O L S A R E G O V E R N E D B YT H E O M P ' S S A M P L I N G G U I D A N C E D O C U M E N T S . A L L I N F O R M A T I O N P R O V I D E D B Y T H E C L I E N T , I N C L U D I N G S E L F S A M P L I N G , M U S T B E A C C U R A T E A N D A D H E R E T O T H E S A M E R U L E S A N DR E G U L A T I O N S . H O W E V E R , C L I E N T P R O V I D E D I N F O R M A T I O N , I N C L U D I N G S A M P L I N G , I S U L T I M A T E L Y T H E R E S P O N S I B I L I T Y O F T H E P R O V I D I N G L I C E N S E E , R E G I S T E R E D C A R E G I V E R , P A T I E N T O RT H E L I K E A N D F A I L U R E T O F O L L O W S A I D P R O T O C O L S C O U L D L E A D T O E R R O N E O U S T E S T R E S U L T S . N O T E : N O T A L L P O T E N T I A L A N D / O R E X I S T I N G H A Z A R D S W E R E A N A L Y Z E D .

E N D O F R E P O R T

N O VA A N A LY T I C L A B S // 6 5 M I L L I K E N S T R E E T, U N I T C P O R T L A N D M E 0 4 1 0 3 // P H : 2 0 7 4 6 6 4 6 6 1

E M A I L : I N N O VAT I O N @ N O VA - A N A LY T I C L A B S . C O M

M E L I C E N S E # : T F 2 8 4

B A T C H N O . : C B G . T . 2 1 . 0 0 1

M A T R I X : T I N C T U R E

D E N S I T Y : 0 . 9 3 6 4 g / m l

S A M P L E I D : N A L - 2 1 1 1 0 5 - 1 4 3

C O L L E C T E D O N : N O V 0 5 , 2 0 2 1

R E C E I V E D O N : N O V 0 5 , 2 0 2 1

S A M P L E S I Z E : 3 . 1 7 8 G

S A M P L E D B Y : S A R A H C H R I S T

R E C E I V E D B Y : K A Y L I N K E I T H

C B G : 3 . 9 3 %

C B G A : 0 . 6 4 3 %

T O T A L C A N N A B I N O I D S : 5 . 6 9 %

C A N N A B I N O I D O V E R V I E W

M A N U F A C T U R E RH E A L E R H E M P L L C1 1 9 O R I O N S TB R U N S W I C K , M A I N E 0 4 0 1 1

L I C E N S EC G R 2 6 4 2 4M E D I C I N A L - C A R E G I V E R

M A N U F A C T U R E R I N F O B A T C H R E S U L T : P A S S E D A S M A I N E I N D U S T R I A LH E M P

P O T E N C Y P A S S

A N A L Y T E L I M I T A M T A M T L O D / L O Q ( m g / m l ) P A S S / F A I L

C B C 0 . 3 4 7 % 3 . 2 5 m g / m l 0 . 0 9 9 3 / 0 . 4 9 7 N / AC B C A < L O Q < L O Q 0 . 0 9 9 3 / 0 . 4 9 7 N / AC B D 0 . 3 6 6 % 3 . 4 3 m g / m l 0 . 0 9 9 3 / 0 . 4 9 7 N / AC B D A 0 . 2 7 2 % 2 . 5 5 m g / m l 0 . 0 9 9 3 / 0 . 4 9 7 N / AC B D V 0 . 0 7 8 4 % 0 . 7 3 4 m g / m l 0 . 0 9 9 3 / 0 . 4 9 7 N / AC B D V A N D N D 0 . 0 9 9 3 / 0 . 4 9 7 N / AC B G 3 . 9 3 % 3 6 . 8 m g / m l 0 . 0 9 9 3 / 0 . 4 9 7 N / AC B G A 0 . 6 4 3 % 6 . 0 2 m g / m l 0 . 0 9 9 3 / 0 . 4 9 7 N / AC B L N D N D 0 . 0 9 9 3 / 0 . 4 9 7 N / AC B L A N D N D 0 . 0 9 9 3 / 0 . 4 9 7 N / AC B N N D N D 0 . 0 9 9 3 / 0 . 4 9 7 N / A

A N A L Y T E L I M I T A M T A M T L O D / L O Q ( m g / m l ) P A S S / F A I L

C B N A N D N D 0 . 0 9 9 3 / 0 . 4 9 7 N / AΔ - T H C N D N D 0 . 0 9 9 3 / 0 . 4 9 7 N / AΔ - T H C 0 . 0 5 8 4 % 0 . 5 4 7 m g / m l 0 . 0 9 9 3 / 0 . 4 9 7 N / AΔ - T H C N D N D 0 . 0 9 9 3 / 0 . 4 9 7 N / AE X O - T H C N D N D 0 . 0 9 9 3 / 0 . 4 9 7 N / AT H C A N D N D 0 . 0 9 9 3 / 0 . 4 9 7 N / AT H C V N D N D 0 . 0 9 9 3 / 0 . 4 9 7 N / AT H C V A N D N D 0 . 0 9 9 3 / 0 . 4 9 7 N / AT O T A L T H C * * 0 . 0 5 8 4 % 0 . 5 4 7 m g / m l N / AT O T A L C B D * * 0 . 6 0 5 % 5 . 6 7 m g / m l N / A

8

9

1 0

R E S U L T S C E R T I F I E D B Y :B A R R Y C H A F F I N

C O O , N O V A A N A L Y T I C L A B SN O V 1 0 , 2 0 2 1

R E S U L T S C E R T I F I E D B Y :G R E G N E W L A N D

C S O , N O V A A N A L Y T I C L A B SN O V 1 0 , 2 0 2 1

R E S U L T S C E R T I F I E D B Y :C H R I S A L T O M A R E

C E O , N O V A A N A L Y T I C L A B SN O V 1 0 , 2 0 2 1

https://lims.tagleaf.com/login?affiliate=nova-analytic-labs


C B G .T. 2 1 . 0 0 1 -T E R P ( T I N C T U R E ) // P RO D U C E D : N OV 1 0 , 2 0 2 1


T E R P E N E S B Y H E A D S PA C E G C- M SP R E PA R AT I O N : N O V 0 8 , 2 0 2 1 // A N A LY S I S : N O V 1 0 , 2 0 2 1

https://lims.tagleaf.com/coa_/nnBNbnJtBU






M E L I C E N S E # : T F 2 8 4

B A T C H N O . : C B G . T . 2 1 . 0 0 1


S A M P L E I D : N A L - 2 1 1 1 0 5 - 1 4 4

C O L L E C T E D O N : N O V 0 5 , 2 0 2 1

R E C E I V E D O N : N O V 0 5 , 2 0 2 1

S A M P L E S I Z E : 3 . 3 7 1 G






T E R P E N E S T E S T E D

A N A L Y T E A M T A M T L O D / L O Q ( m g / g ) P A S S / F A I L

T O T A L T E R P E N E S 0 . 2 6 9 % 2 . 6 9 m g / g N / AC A M P H E N E N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / AG E R A N I O L N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / AL I N A L O O L N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / AP - C Y M E N E N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / AE U C A L Y P T O L N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / AI S O P U L E G O L N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / AD - L I M O N E N E N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / AT E R P I N O L E N E N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / Aβ - P I N E N E N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / Aα - P I N E N E N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / Aβ - M Y R C E N E 0 . 0 1 9 7 % 0 . 1 9 7 m g / g 0 . 0 9 5 9 / 0 . 1 9 2 N / A

A N A L Y T E A M T A M T L O D / L O Q ( m g / g ) P A S S / F A I L

β - O C I M E N E N D N D 0 . 0 4 7 9 / 0 . 0 9 5 9 N / Aα - O C I M E N E N D N D 0 . 0 4 7 9 / 0 . 0 9 5 9 N / AC I S - N E R O L I D O L N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / AΔ - C A R E N E N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / Aα - H U M U L E N E 0 . 0 4 0 4 % 0 . 4 0 4 m g / g 0 . 0 9 5 9 / 0 . 1 9 2 N / Aα - B I S A B O L O L 0 . 0 2 8 2 % 0 . 2 8 2 m g / g 0 . 0 9 5 9 / 0 . 1 9 2 N / Aα - T E R P I N E N E N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / Aγ - T E R P I N E N E N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / AT R A N S - N E R O L I D O L N D N D 0 . 0 9 5 9 / 0 . 1 9 2 N / Aβ - C A R Y O P H Y L L E N E 0 . 1 6 1 % 1 . 6 1 m g / g 0 . 0 9 5 9 / 0 . 1 9 2 N / AC A R Y O P H Y L L E N E O X I D E 0 . 0 1 9 6 % 0 . 1 9 6 m g / g 0 . 0 9 5 9 / 0 . 1 9 2 N / A

3









C B G .T. 2 1 . 0 0 1 - C O N T ( T I N C T U R E ) // P RO D U C E D : N OV 1 1 , 2 0 2 1


R S O L . 1 : R E S I D U A L S O LV E N T S , P O I S O N S A N D T O X I N S B Y H E A D S PA C E G C- M SP R E PA R AT I O N : N O V 0 8 , 2 0 2 1 // A N A LY S I S : N O V 0 9 , 2 0 2 1

https://lims.tagleaf.com/coa_/sfbM7txbL0



M E L I C E N S E # : T F 2 8 4

B A T C H N O . : C B G . T . 2 1 . 0 0 1


S A M P L E I D : N A L - 2 1 1 1 0 5 - 1 4 5

C O L L E C T E D O N : N O V 0 5 , 2 0 2 1

R E C E I V E D O N : N O V 0 5 , 2 0 2 1

S A M P L E S I Z E : 6 . 4 4 0 G






M E T A L S T E S T E D

M I C R O B I A L T E S T E D

S O L V E N T S T E S T E D

A N A L Y T E L I M I T A M T ( µ g / g ) L O D / L O Q ( µ g / g ) P A S S / F A I L

B U T A N E 5 0 0 0 µ g / g N D 1 . 5 5 / 3 . 8 8 N / AH E X A N E 2 9 0 µ g / g N D 1 . 5 5 / 3 . 8 8 N / AA C E T O N E 5 0 0 0 µ g / g N D 7 . 7 5 / 1 5 . 5 N / AB E N Z E N E 1 µ g / g N D 0 . 7 7 5 / 1 . 5 5 N / AE T H A N O L 5 0 0 0 µ g / g 2 8 5 1 5 . 5 / 3 1 . 0 N / AH E P T A N E 5 0 0 0 µ g / g N D 1 5 . 5 / 3 1 . 0 N / AP E N T A N E 5 0 0 0 µ g / g N D 1 5 . 5 / 3 1 . 0 N / AP R O P A N E 5 0 0 0 µ g / g N D 3 1 . 0 / 6 2 . 0 N / AT O L U E N E 8 9 0 µ g / g N D 7 . 7 5 / 1 5 . 5 N / AM E T H A N O L 3 0 0 0 µ g / g N D 1 5 . 5 / 7 7 . 5 N / AO - X Y L E N E 2 1 7 0 µ g / g N D 1 . 5 5 / 7 . 7 5 N / A

A N A L Y T E L I M I T A M T ( µ g / g ) L O D / L O Q ( µ g / g ) P A S S / F A I L

C H L O R O F O R M 1 µ g / g N D 0 . 7 7 5 / 1 . 5 5 N / AE T H Y L E T H E R 5 0 0 0 µ g / g N D 1 5 . 5 / 3 1 . 0 N / AA C E T O N I T R I L E 4 1 0 µ g / g N D 1 5 . 5 / 3 1 . 0 N / AE T H Y L A C E T A T E 5 0 0 0 µ g / g N D 1 5 . 5 / 3 1 . 0 N / AE T H Y L E N E O X I D E 1 µ g / g N D 0 . 7 7 5 / 1 . 5 5 N / AP - A N D M - X Y L E N E 2 1 7 0 µ g / g N D 3 . 1 0 / 7 . 7 5 N / AI S O P R O P Y L A L C O H O L 5 0 0 0 µ g / g N D 3 1 . 0 / 6 2 . 0 N / AT R I C H L O R O E T H Y - L E N E

1 µ g / g N D 0 . 7 7 5 / 1 . 5 5 N / A

1 , 2 - D I C H L O R O E T H A N E

1 µ g / g N D 0 . 7 7 5 / 1 . 5 5 N / A

M E T H Y L E N E C H L O R I D E 1 µ g / g N D 0 . 7 7 5 / 1 . 5 5 N / A








H M E . 1 : H E AV Y M E TA L S B Y I C P - M SP R E PA R AT I O N : N O V 0 8 , 2 0 2 1 // A N A LY S I S : N O V 0 9 , 2 0 2 1

M I C . 3 : T O TA L C O L I F O R M B Y M O S T P R O B A B L E N U M B E RP R E PA R AT I O N : N O V 0 8 , 2 0 2 1 // A N A LY S I S : N O V 0 9 , 2 0 2 1

M I C . 6 : T O TA L E N T E R O B A C T E R B Y M O S T P R O B A B L E N U M B E RP R E PA R AT I O N : N O V 0 8 , 2 0 2 1 // A N A LY S I S : N O V 0 9 , 2 0 2 1

T O TA L A E R O B I C B A C T E R I A B Y M O S T P R O B A B L E N U M B E RP R E PA R AT I O N : N O V 0 8 , 2 0 2 1 // A N A LY S I S : N O V 0 9 , 2 0 2 1

M I C . 5 : S A L M O N E L L A B Y P C RP R E PA R AT I O N : N O V 0 8 , 2 0 2 1 // A N A LY S I S : N O V 1 1 , 2 0 2 1

M I C . 4 : PAT H O G E N I C E . C O L I B Y P C RP R E PA R AT I O N : N O V 0 8 , 2 0 2 1 // A N A LY S I S : N O V 1 1 , 2 0 2 1

T O TA L Y E A S T A N D M O L D B Y M O S T P R O B A B L E N U M B E RP R E PA R AT I O N : N O V 0 8 , 2 0 2 1 // A N A LY S I S : N O V 1 1 , 2 0 2 1




A N A L Y T E L I M I T A M T ( µ g / k g ) L O D / L O Q ( µ g / k g ) P A S S / F A I L

L E A D 5 0 0 µ g / k g N D 3 4 . 9 / 1 0 5 N / AA R S E N I C 1 5 0 0 µ g / k g N D 3 4 . 9 / 8 7 . 3 N / A


C A D M I U M 5 0 0 µ g / k g N D 3 4 . 9 / 8 7 . 3 N / AM E R C U R Y 3 0 0 0 µ g / k g N D 3 4 . 9 / 6 9 . 8 N / A

A N A L Y T E L I M I T A M T ( C F U / g ) L O D / L O Q ( C F U / g ) P A S S / F A I L

C O L I F O R M S 1 0 0 0 C F U / g N D 1 0 0 / 1 0 0 N / A


E N T E R O B A C T E R I A C E A E 1 0 0 0 C F U / g N D 1 0 0 / 1 0 0 N / A


A E R O B I C B A C T E R I A 1 0 0 0 0 0 C F U / g N D 1 0 0 / 1 0 0 N / A


S A L M O N E L L AS P P .

A n y a m t i n 1g r a m

N D 1 . 0 0 / 1 . 0 0 N / A


E S C H E R I C H I AC O L I

A n y a m t i n 1g r a m

N D 1 . 0 0 / 1 . 0 0 N / A


Y E A S T & M O L D 1 0 0 0 0 C F U / g N D 1 0 0 / 1 0 0 N / A

Page 2 of 2https://lims.tagleaf.com/coa_/sfbM7txbL0


H . 2 1 - 0 0 1 P E S T I C I D E T E S T ( T I N C T U R E ) // P RO D U C E D : J U L 0 6 , 2 0 2 1


P E S . 1 : P E S T I C I D E S , I N S E C T I C I D E S , F U N G I C I D E S A N D G R O W T H R E G U L AT O R S B Y L C- M S / M SP R E PA R AT I O N : J U L 0 2 , 2 0 2 1 // A N A LY S I S : J U L 0 2 , 2 0 2 1

https://lims.tagleaf.com/coa_/sVTqDHmMyf






M E L I C E N S E # : T F 2 8 4

B A T C H N O . : H . 2 1 - 0 0 1


S A M P L E I D : N A L - 2 1 0 7 0 2 - 0 1 5

C O L L E C T E D O N : J U L 0 2 , 2 0 2 1

R E C E I V E D O N : J U L 0 2 , 2 0 2 1

S A M P L E S I Z E : 3 . 9 3 6 G




P E S T I C I D E S T E S T E D


I M A Z A L I L N D 2 . 8 6 / 5 . 7 2 N / AE T O X A Z O L E N D 2 . 8 6 / 5 . 7 2 N / AB I F E N T H R I N N D 2 . 8 6 / 5 . 7 2 N / AC Y F L U T H R I N N D 2 8 . 6 / 2 8 . 6 N / A


D A M I N O Z I D E N D 2 8 . 6 / 2 8 . 6 N / AM Y C L O B U T A N I L N D 1 . 4 3 / 5 . 7 2 N / AS P I R O M E S I F E N N D 2 . 8 6 / 5 . 7 2 N / AT R I F L O X Y S T R O B - I N

N D 1 . 4 3 / 5 . 7 2 N / A


C O O , N O V A A N A L Y T I C L A B SJ U L 0 6 , 2 0 2 1


C S O , N O V A A N A L Y T I C L A B SJ U L 0 6 , 2 0 2 1


C E O , N O V A A N A L Y T I C L A B SJ U L 0 6 , 2 0 2 1


healer products certificates of analysis (coa)

Documents